BSECompany Update30 Sept 2026 · 30 Sept 2026, 06:52 pm
Update on disclosure dated 28 September 2026 on the intimation of acquisition of equity shares of Bliss GVS Pharma Limited.
Anupam Rasayan India Ltd · 543275
✦ AI SummaryM&A
Anupam Rasayan India Ltd has clarified its earlier disclosure regarding the acquisition of equity shares of Bliss GVS Pharma Limited, correcting typographical errors and providing details on the consummation of the transaction.
Analysis Scores
Earnings Impact2/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Anupam Rasayan India Ltd - 543275 - Announcement Under Regulation 30 Of SEBI (LODR) - Update
Attachments (1)
📄pdf
Download →
10cbd810-e725-4fc9-8508-bd3746e5d5ba.pdf
View document text
ANUPAM RASAYAN INDIA LTD.
ARILSLDSTX20260930068 Date: September 30, 2026
To, T o ,
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, ‘Exchange Plaza’, C-1, Block-G,
Dalal Street, Bandra Kurla Complex, Bandra (East),
Mumbai-400001, India Mumbai-400051, India
SCRIP CODE: 543275 SYMBOL: ANURAS
Dear Sir/Madam,
Subject: Disclosure dated 28 September 2026 on the intimation of acquisition of equity shares of Bliss
GVS Pharma Limited (“Bliss”) under the share purchase agreement dated 23 May 2026 (“SPA”) executed
among Anupam Rasayan India Limited (the “Acquirer”) and Narsimha Shibroor Kamath, Vibha Gagan
Sharma, Shruti Vishal Rao, Gautam Rasiklal Ashra, Arjun Gautam Ashra and Gulbarga Trading and
Investment Private Limited (collectively “Sellers”) read with the deed of adherence dated 17 July 2026
(“Deed of Adherence”) executed between the Acquirer and Mates Visa Consultancy Private Limited (the
“PAC”) pursuant to the open offer, and other acquisition of equity shares of Bliss.
Ref: Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure
Requirements) Regulations, 2015 – Clarification.
Dear Sir/Madam,
This has reference to our earlier disclosure vide reference number ARILSLDSTX20260928066 dated 28
September 2026 (“Previous Disclosure”). In this connection, we wish to inform you that, there are certain
inadvertent typographical errors in the Previous Disclosure.
Following are the clarifications in connection with the Previous Disclosure:
a) The Acquirer along with PAC have consummated the transactions under the SPA i.e., the Underlying
Transaction, on 28 September 2026, and the SPA shares constituting 5,09,84,595 equity shares of Bliss
representing 47.95% have been acquired by the PAC.
b) The reference to “1,699 equity shares” of Bliss that have been credited to the demat account of the
Acquirer on 24 August 2026, should be read as “1,669 equity shares”.
To summarise, following are the acquisitions done by the Acquirer and PAC of equity shares of Bliss:
a) Acquirer: 22,51,669 (22,50,000 + 1,669); and
b) PAC: 5,09,84,595.
All other contents of the Previous Disclosure remain unchanged.
This intimation will also be hosted on the website of the Company at www.anupamrasayan.com.
We request you to kindly take note the same.
Registered Office: Tel. : +91-261-2398991-95
Office Nos. 1101 to 1107, 11th Floor, Icon Rio, Fax : +91-261-2398996
Behind Icon Business Centre, Dumas Road, E-mail : office@anupamrasayan.com
Surat-395007, Gujarat, India.
Website : www.anupamrasayan.com
CIN - L24231GJ2003PLC042988
ANUPAM RASAYAN INDIA LTD.
Thanking you,
Yours Faithfully,
For Anupam Rasayan India Limited
Ashish Gupta
Company Secretary & Compliance Officer
Registered Office: Tel. : +91-261-2398991-95
Office Nos. 1101 to 1107, 11th Floor, Icon Rio, Fax : +91-261-2398996
Behind Icon Business Centre, Dumas Road, E-mail : office@anupamrasayan.com
Surat-395007, Gujarat, India.
Website : www.anupamrasayan.com
CIN - L24231GJ2003PLC042988